about
Trypanocidal activity of marine natural productsA long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malariaClavatadine A, a natural product with selective recognition and irreversible inhibition of factor XIaTwo-pronged attack: dual inhibition of Plasmodium falciparum M1 and M17 metalloaminopeptidases by a novel series of hydroxamic acid-based inhibitorsPotent dual inhibitors of Plasmodium falciparum M1 and M17 aminopeptidases through optimization of S1 pocket interactionsOpen Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and BeyondDiversity-oriented synthesis yields novel multistage antimalarial inhibitorsIdentification of compounds with anti-proliferative activity against Trypanosoma brucei brucei strain 427 by a whole cell viability based HTS campaignPCaAnalyser: a 2D-image analysis based module for effective determination of prostate cancer progression in 3D culturePyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparum.Biological characterization of chemically diverse compounds targeting the Plasmodium falciparum coenzyme A synthesis pathwayChemical genetics of Plasmodium falciparumA novel multiple-stage antimalarial agent that inhibits protein synthesisRecent highlights in anti-protozoan drug development and resistance research.The response of fenestrations, actin, and caveolin-1 to vascular endothelial growth factor in SK Hep1 cells.Progress toward establishing an open access molecular screening capability in the Australasian region.(+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium.A luciferase based viability assay for ATP detection in 384-well format for high throughput whole cell screening of Trypanosoma brucei brucei bloodstream form strain 427.Antimalarial activity of natural product extracts from Papua New Guinean and Australian plants against Plasmodium falciparum.Antimalarial activity of azafluorenone alkaloids from the Australian tree Mitrephora diversifolia.Antimalarial benzylisoquinoline alkaloid from the rainforest tree Doryphora sassafras.Antimalarial bromotyrosine derivatives from the Australian marine sponge Hyattella sp.Repositioning: the fast track to new anti-malarial medicines?Facile Synthesis and Preliminary Structure-Activity Analysis of New Sulfonamides Against Trypanosoma bruceiLysine acetylation in sexual stage malaria parasites is a target for antimalarial small molecules.A new quinoline epoxide from the Australian plant Drummondita calida.Screening and hit evaluation of a chemical library against blood-stage Plasmodium falciparum.Convolutamines I and J, antitrypanosomal alkaloids from the bryozoan Amathia tortusa.Alkaloids from the Chinese vine Gnetum montanum.Development and optimization of a novel 384-well anti-malarial imaging assay validated for high-throughput screening3,5-Diaryl-2-aminopyridines as a novel class of orally active antimalarials demonstrating single dose cure in mice and clinical candidate potential.A novel approach for the discovery of chemically diverse anti-malarial compounds targeting the Plasmodium falciparum Coenzyme A synthesis pathway.Ianthelliformisamines A-C, antibacterial bromotyrosine-derived metabolites from the marine sponge Suberea ianthelliformis.Quinolone-3-diarylethers: a new class of antimalarial drug.Whole-cell in vitro screening for gametocytocidal compounds.Whole-organism high-throughput screening against Trypanosoma brucei brucei.Polydiscamides B-D from a marine sponge Ircinia sp. as potent human sensory neuron-specific G protein coupled receptor agonists.(-)-Dibromophakellin: an alpha2B adrenoceptor agonist isolated from the Australian marine sponge, Acanthella costata.Thiaplakortones A-D: antimalarial thiazine alkaloids from the Australian marine sponge Plakortis lita.Identification of MMV malaria box inhibitors of plasmodium falciparum early-stage gametocytes using a luciferase-based high-throughput assay.
P50
Q27008593-66FCA628-480D-4A8A-816B-19C754DF9A29Q27644391-B041C15E-AD59-4C4B-9601-1F61A71A3275Q27650708-3C8F08B5-4CC2-47B7-905C-BE739CFA9001Q27695695-4E9CE659-73C2-4A11-926A-81280B698B52Q27703729-CB376880-E70A-4D77-8E23-42D8215C28B8Q27826351-422E3A81-9AB8-43E5-93D7-402FAF557A72Q27861934-B05DAEEB-728A-4ED4-9E4D-F98172F8C4B3Q28485372-374593E9-1AB7-4AA6-B277-D8C453ACD784Q28535321-69F378CB-C6F2-43F1-8832-390C89CDE58EQ28649962-9681D50C-D3F0-42AB-B36F-B2313EF3C0F8Q28821118-F330BF5F-09A5-47C7-BBED-5F6AC2D5120BQ29617272-B9D36FED-C522-43EE-A8D2-744F4404F89EQ30044020-37AE9187-8DA4-4B55-B2A7-20601556F569Q30414810-CA23EB2E-C875-4664-9F17-F2BE8D2DB2E3Q30482967-9EABE3F4-E36E-40F6-AC76-75C023E9D2FCQ30483658-734E7D5E-3D35-47A6-82F4-49884DA18D4BQ30610467-0200AA2C-525E-43A6-91BD-5FB2F45662E9Q30883740-26B9F43E-FD38-4D7A-BC39-1A3A49DA26AEQ33359126-0D400F21-7B0E-4B6E-842C-192B0DAC0F74Q33480632-003B6DC9-51A9-4128-B961-EF944D5C5343Q33488023-7D61593B-67CB-42A0-9347-0518850DED5EQ33576225-57C8E374-AF58-44A5-851C-540F371A09CDQ33612012-4B3C66EA-46C1-4B1C-A5AC-452F50A5F6C4Q33636542-F1C8B2CA-A007-458D-8B6D-7706069778A2Q33798591-4069CE58-95B4-46F1-8692-CDC1355B0A96Q33864889-D46A3A65-7841-4E12-B5F7-0B087F807A26Q33891625-322D2A0A-177E-474C-871D-3DC69948FAFEQ33943104-308E45AA-8825-4928-82E0-14D488E7A96BQ34062766-2189A0AB-4E7D-49FB-A2A6-49457CBD359AQ34122581-4B561AB9-8774-4600-A64E-9957CFED54A2Q34184919-3B41549E-8D98-46D2-845B-A0AF59DACCD4Q34208175-973E04A6-EA1E-4248-A82D-402F17699991Q34239261-7AEABB25-6347-4FFB-BB85-A6124EE96CABQ34334269-F1821884-09D8-486B-857B-EAD200104D77Q34509609-266091BB-4DE2-4A66-81CE-39F18408670DQ34642037-C742AE0D-6AC9-444B-9C9F-74D01CFC05F4Q34731190-F1CD568B-B296-4721-9C48-1DA5124D620AQ34952121-347033CB-84B7-4B84-BC46-1443F341FA10Q34986468-CF66FF00-D4F3-4957-B5DB-A2E32F003468Q34995863-8185A1A5-2A01-4CC7-8E71-BDF8EEF03867
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Vicky M Avery
@es
Vicky M. Avery
@en
Vicky M. Avery
@nl
Vicky M. Avery
@sl
type
label
Vicky M Avery
@es
Vicky M. Avery
@en
Vicky M. Avery
@nl
Vicky M. Avery
@sl
altLabel
Vicky Avery
@en
prefLabel
Vicky M Avery
@es
Vicky M. Avery
@en
Vicky M. Avery
@nl
Vicky M. Avery
@sl
P1053
A-5449-2010
P106
P1153
55879200700
P21
P31
P3829
P496
0000-0003-4914-2299
P569
2000-01-01T00:00:00Z